Transgelin-2 interacts with CD44 to regulate Notch1 signaling pathway and participates in colorectal cancer proliferation and migration

[1]  Jingwen Liu,et al.  Transgelins: Cytoskeletal Associated Proteins Implicated in the Metastasis of Colorectal Cancer , 2020, Frontiers in Cell and Developmental Biology.

[2]  Youkui Han,et al.  Long Noncoding RNA DSCAM-AS1 Facilitates Colorectal Cancer Cell Proliferation and Migration via miR-137/Notch1 Axis , 2020, Journal of Cancer.

[3]  H. Clevers,et al.  Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[4]  C. Damodaran,et al.  A Review on Notch Signaling and Colorectal Cancer , 2020, Cells.

[5]  A. Jemal,et al.  Colorectal cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[6]  J. Hasselby,et al.  ERCC1 expression in advanced colorectal cancer and matched liver metastases. , 2020, Pathology, research and practice.

[7]  J. Jin,et al.  DOWN-REGULATION OF CALPONIN 2 CONTRIBUTES TO THE QUIESCENCE OF LUNG MACROPHAGES. , 2019, American journal of physiology. Cell physiology.

[8]  Yuwu Zhao,et al.  USP18 Overexpression Protects against Focal Cerebral Ischemia Injury in Mice by Suppressing Microglial Activation , 2019, Neuroscience.

[9]  W. Duan,et al.  Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements , 2019, Microscopy and Microanalysis.

[10]  Yongmei Li,et al.  Ubiquitination and Long Non-coding RNAs Regulate Actin Cytoskeleton Regulators in Cancer Progression , 2019, International journal of molecular sciences.

[11]  Lei Zheng,et al.  Notch pathway is involved in the suppression of colorectal cancer by embryonic stem cell microenvironment , 2019, OncoTargets and therapy.

[12]  G. Fountzilas,et al.  Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer , 2019, AntiCancer Research.

[13]  J. Morgado-Díaz,et al.  Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells. , 2019, Biochimica et biophysica acta. Molecular cell research.

[14]  M. Najafi,et al.  Cancer stem cells (CSCs) in cancer progression and therapy , 2018, Journal of cellular physiology.

[15]  C. Chen,et al.  The biology and role of CD44 in cancer progression: therapeutic implications , 2018, Journal of Hematology & Oncology.

[16]  M. Flentje,et al.  Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma. , 2017, Oncology reports.

[17]  J. Tabernero,et al.  Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Bo Zhang,et al.  LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics , 2017, Oncotarget.

[19]  Yinghui Li,et al.  Actin cytoskeleton mediates BMP2-Smad signaling via calponin 1 in preosteoblast under simulated microgravity. , 2017, Biochimie.

[20]  Si-ying Chen,et al.  Transgelin-2: A potential oncogenic factor , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[21]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[22]  M. Deenen,et al.  Recommendation on testing for dihydropyrimidine dehydrogenase deficiency in the ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  F. E. Bertrand,et al.  The Notch pathway in colorectal cancer , 2016, International journal of cancer.

[25]  D. Shen,et al.  Identification of transgelin‐2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis , 2010, Cancer science.

[26]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[27]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.